Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA publishes risk levels of experts based on industry connections

This article was originally published in Scrip

Executive Summary

The European Medicines Agency has published the "risk levels" of all the experts that are involved in its drug regulatory activities, based on the interests they have declared in relation to the pharmaceutical industry. The risk levels are used together with the declarations of interests to determine the extent to which a particular expert can take part in the agency's drug authorisation and surveillance operations.

Topics

Related Companies

UsernamePublicRestriction

Register

SC016464

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel